QQ客服 官方微博 反馈留言

浏览/检索结果: 共94条，第1-10条 帮助 限定条件 发表日期：2017    专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Prognostic and predictive value of serum carcinoembryonic antigen levels in advanced non-small cell lung cancer patients with epidermal growth factor receptor sensitive mutations and receiving tyrosine kinase inhibitors 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 41 作者:  Zhao, Xin Min;  Zhao, Jing;  Xing, Kai Lin;  Sun, Si;  Luo, Zhi Guo 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 non-small cell lung cancer  chemotherapy  epidermal growth factor receptor  tyrosine kinase inhibitors  carcinoembryonic antigen   Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 7 作者:  Gong, Xiaomei;  Li, Xuefei;  Jiang, Tao;  Xie, Huikang;  Zhu, Zhengfei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Programmed death ligand 1  Radiation resistance  Tumor-infiltrating regulatory T cells  Myeloid-derived suppressor cells  PI3K/AKT pathway   A randomized, multi-center, double-blind phase II study of fruquintinib in patients with advanced non-small cell lung cancer 期刊论文 Journal of Thoracic Oncology, 2017, 卷号: 12 作者:  Lu S., Chang J., Liu X., Shi J., Lu Y., Li W., Yang J., Zhou J., Wang J., Yang L., Chen Z., Zhou X., Liu Z., Hua Y., Su W. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs) 会议论文 作者:  Soo, R.;  Mok, T. S. K.;  Shi, Y-K.;  Zhang, L.;  Lu, S. 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05 Randomized Controlled Study Comparing Adjuvant versus Neo-Adjuvant Chemotherapy in Resectable Stage IB to IIIA NSCLC 会议论文 作者:  Wu, Yi Long;  Yang, Xue-Ning;  Zhong, Wen-Zhao;  Ben, Xiao-Song;  Luo, Hong-He 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 ADJUVANT  non-small cell lung cancer  neoadjuvant  chemotherapy   Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients 期刊论文 SCIENTIFIC REPORTS, 2017, 卷号: 7 作者:  Jiao, Lijing;  Dong, Changsheng;  Liu, Jiaxiang;  Chen, Zhiwei;  Zhang, Lei 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 MCMs expression in lung cancer: implication of prognostic significance 期刊论文 JOURNAL OF CANCER, 2017, 卷号: 8, 期号: 18 作者:  Jiang, Yan-Yi;  Liu, Yi-Zhen;  Cai, Yan;  Wang, Ming-Rong;  Xu, Xin 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Non-small cell lung cancer  Prognosis  Biomarker  MCM2  MCM5  MCM6   Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status 期刊论文 SCIENTIFIC REPORTS, 2017, 卷号: 7 作者:  Jian, Hong;  Li, Wei;  Ma, Zhiyong;  Huang, Jianjin;  Feng, Jifeng 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Characteristics of exceptional long term survivors in extensive stage small cell lung cancer 期刊论文 Journal of Thoracic Oncology, 2017, 卷号: 12 作者:  Maneenil K., Molina J., She J., Gupta R., Aubry M., Yi E., Yang P. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文 作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05